Postherpes zoster programmed death-1 inhibitor-associated zosteriform granulomatous reactions

Simran A Chadha; Lida Zheng; Joel C Sunshine; Lauren M Guggina; Cuong V Nguyen

doi:10.1016/j.jdcr.2020.09.017

Postherpes zoster programmed death-1 inhibitor-associated zosteriform granulomatous reactions

JAAD Case Rep. 2020 Oct 7;6(12):1201-1204. doi: 10.1016/j.jdcr.2020.09.017. eCollection 2020 Dec.

Authors

Simran A Chadha¹, Lida Zheng², Joel C Sunshine², Lauren M Guggina², Cuong V Nguyen²

Affiliations

¹ Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

No abstract available

Keywords: GA, granuloma annulare; GD, granulomatous dermatitis; ICPI, immune checkpoint inhibitor; PD-1, programmed death-1; granulomatous; immune-related adverse event; pembrolizumab; programmed death-1; zosteriform.

Publication types

Case Reports